What brings pericytes to tumor vessels?

Journal of Clinical Investigation

Volumn 112, Issue 8, 2003, Pages 1134-1136

  Jain, Rakesh K ^a,b   Booth, Michael F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Edwin L Steele Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; ENDOTHELIUM CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; REVIEW; TUMOR BLOOD FLOW;

ANIMALS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; MICE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0346727319     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200320087     Document Type: Review

References (18)

1. Jain, R.K. 2003. Molecular regulation of vessel maturation. Nat. Med. 9:685-693.
2. Jain, R.K. 1994. Barriers to drug delivery in solid tumors. Sci. Am. 271:58-65.
3. Hellstrom, M., et al. 2001. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153:543-553.
4. Abramsson, A., Lindblom, P., and Betsholtz, C. 2003. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112:1142-1151. doi:10.1172/JCI200318549.
5. Lindblom, P., et al. 2003. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17:1835-1840.
6. Carmeliet, P. 2003. Angiogenesis in health and disease. Nat. Med. 9:653-660.
7. Fukumura, D., et al. 1998. Tumor induction of VEGF promoter activity in stromal cells. Cell. 94:715-725.
8. Brown, E.B., et al. 2001. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat. Med. 7:864-868.
9. Reinmuth, N., et al. 2001. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J. 15:1239-1241.
10. Benjamin, L.E., Golijanin, D., Itin, A., Pode, D., and Kesher, E. 1999. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103:159-165.
11. Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., and Hanahan, D. 2003. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:1287-1295. doi:10.1172/JCI200317929.
12. Jain, R.K. 2001. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. 7:987-989.
13. Hurwitz, H., et al. 2003. Bevacizumab (Avastin, a monoclonal antibody to vascular endothelial growth factor) prolongs survival in first-line colorectal cancer (CRC): results of a phase III trial of bevacizumab in combination with bolus IFL (irinotecan, 5-fluorouracil, leucovorin) as first-line therapy in subjects with metastatic CRC. Proceedings of the American Society of Clinical Oncology. 22:2107. (Abstr.)
14. Hirschi, K.K., Rohovsky, S.A., and D'Amore, P.A. 1998. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141:805-814.
15. Chambers, R.C., Leoni, P., Kaminski, N., Laurent, G.J., and Heller, R.A. 2003. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. Am. J. Pathol. 162:533-546.
16. Kadambi, A., et al. 2001. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res. 61:2404-2408.
17. Morikawa, S., et al. 2002. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160:985-1000.
18. Hobbs, S.K., et al. 1998. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U. S. A. 95:4607-4612.